Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Orange
Clinical trial register · Australia

Clinical Trials in Orange, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca6 Merck Sharp & Dohme LLC3 BeOne Medicines3 University of Sydney2 Amgen2
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Orange

29 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Pfizer
Phase 3
1,000
Orange, Wahroonga, South Brisbane, Kurralta Park, Nedlands
2025-09-28
Recruiting
Amgen
Phase 3
11,000
Garran, Camperdown, Charlestown, Concord, Merewether, Orange, Wollongong, Auchenflower
2025-08-22
Recruiting
AstraZeneca
Phase 3
700
Kingswood, Murdoch, Orange, South Brisbane, St Leonards, Waratah, Woolloongabba
2025-08-06
Not yet open
Virtual Reality for Vocational Recovery
NCT07114887Mental Health Disorder
Orygen
Not applicable
20
Orange, Melbourne, Perth
2025-08
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Canberra, North Tamworth, Orange, Brisbane, Elizabeth Vale, Frankston, Melbourne, Traralgon
2025-04-24
Recruiting
Tissue Repair Gel in Venous Leg Ulcers in AU/US
NCT06707103Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis
DrugGlucoprime
TR Therapeutics
Phase 3
312
Camperdown, Kogarah, Orange, Sydney, Bendigo, Ivanhoe, Shepparton, Nedlands
2025-04
Recruiting
Locally Optimised Contouring With AI Technology for Radiotherapy
NCT06546592Contouring, Segmentation, Radiation Therapy, Artificial Intelligence
Royal North Shore Hospital
Not applicable
444
Dubbo, Orange, St Leonards
2025-02-11
Active, closed
Amgen
Phase 1
49
Orange, Woodville South
2024-09-17
Recruiting
Omico
Phase 2
96
Albury, Coffs Harbour, Orange, Port Macquarie, Cairns, Rockhampton, Toowoomba, Townsville
2023-12-15
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Garran, Camperdown, Caringbah, Darlinghurst, Gosford, Kingswood, Orange, Saint Leonards
2023-04-26
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
Bankstown, Orange, Clayton, Melbourne
2023-04-04
Active, closed
Bristol-Myers Squibb
Phase 3
579
Coffs Harbour, Orange, Port Macquarie, Wagga Wagga, Waratah, Westmead, Wollstonecraft, Birtinya
2023-03-06
Recruiting
Fore Biotherapeutics
Phase 2
254
New Lambton Heights, Orange, Randwick, Bedford Park, Melbourne
2023-02-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Orange, Adelaide, Frankston
2023-02-06
Active, closed
BeiGene
Phase 1/2
113
Blacktown, Orange, Wagga Wagga, Waratah, Benowa, Clayton, Melbourne, Murdoch
2023-01-29
Active, closed
AstraZeneca
Phase 3
1,035
Birtinya, Greenslopes, Kogarah, North Adelaide, Orange, Redcliffe, Wahroonga
2022-03-25
Active, closed
BeOne Medicines
Phase 3
799
Concord, Gosford, Kogarah, Orange, Port Macquarie, Westmead, Douglas, North Adelaide
2022-03-10
Active, closed
Combination Immunotherapy in Rare Cancers Under InvesTigation
NCT04969887Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Neoplasm, MSI-H Solid Malignant Tumor
DrugsYervoy·Ipilimumab·Opdivo·Nivolumab
Olivia Newton-John Cancer Research Institute
Phase 2
240
Albury, Orange, Sydney, Waratah, Cairns, Douglas, Townsville, Adelaide
2021-08-03
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Concord, Kogarah, Orange, Southport, Clayton, Fitzroy, Heidelberg, Melbourne
2021-05-24
Active, closed
AstraZeneca
Phase 3
1,012
Birtinya, Darlinghurst, Kingswood, Orange, South Brisbane
2020-07-13
Active, closed
AstraZeneca
Phase 3
818
Adelaide, Ballarat, Birtinya, Box Hill, Concord, Kurralta Park, North Sydney, Orange
2020-04-16
Active, closed
BeOne Medicines
Phase 1
437
Concord, Orange, Benowa, Tugun, Adelaide, Bedford PK, Box Hill, Clayton
2020-03-24
Active, closed
AstraZeneca
Phase 3
1,246
Box Hill, Elizabeth Vale, Kogarah, Macquarie University, Murdoch, Orange, South Brisbane, St Albans
2018-09-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Camperdown, Liverpool, Macquarie University, North Sydney, Orange, Port Macquarie, St Leonards, Waratah
2018-08-21
Active, closed
AstraZeneca
Phase 3
1,018
Auchenflower, Box Hill, Brisbane, Kogarah, Orange, Parkville, Westmead, Wollongong
2018-05-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Orange, Westmead
2018-04-24
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Bowral, Coffs Harbour, Gateshead, Gosford, Macquarie Park, Orange, Wollongong, Brisbane
2015-08
Active, closed
University of Sydney
Phase 3
1,125
Camperdown, Coffs Harbour, Concord, Darlinghurst, Kingswood, Kogarah, Orange, Port Macquarie
2014-03
Active, closed
University of Sydney
Phase 3
802
Blacktown, Campbelltown, Camperdown, Gateshead, Gosford, Kogarah, Liverpool, Orange
2014-03
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/orange

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Orange.

How many clinical trials are recruiting in Orange?

10 of the 29 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Orange), 29 studies
PhaseStudiesRecruitingShare
Phase 319665.5%
Phase 13010.3%
Phase 23210.3%
Not applicable216.9%
Phase 1/2216.9%

Most active sponsors

Lead sponsors with the most studies (Orange)
Lead sponsorStudiesRecruiting
AstraZeneca61
BeOne Medicines31
Merck Sharp & Dohme LLC31
Amgen21
University of Sydney20
AbbVie10
Alliance Foundation Trials, LLC.10
Australian and New Zealand Intensive Care Research Centre10
BeiGene10
Bristol-Myers Squibb10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.